Nanohale AG (ETR:FYB) | WebDisclosure

PRESS RELEASE

published on 09/17/2025 at 06:30, 9 months 11 days ago

Horus Pharma becomes additional commercialization partner for Formycon's Eylea® biosimilar FYB203 in selected European countries under the brand name Baiama®
Horus Pharma partners with Formycon for Eylea biosimilar commercialization in Europe under Baiama brand. Agreement includes upfront payments and royalties for Klinge. Aflibercept treats nAMD

Agreement Formycon Eylea Biosimilar Horus Pharma Baiama Brand
BRIEF

published on 08/13/2025 at 06:35, 10 months 15 days ago

Formycon confirme ses perspectives pour l'ensemble de l'année après des développements stratégiques

Formycon AG Obligations D'entreprise Orientations Financières 2025 Marché Des Biosimilaires FYB202 Et FYB206
BRIEF

published on 08/13/2025 at 06:35, 10 months 15 days ago

Formycon Affirms Full-Year Outlook After Strategic Developments

Formycon AG Corporate Bond Biosimilar Market 2025 Financial Guidance FYB202 & FYB206
PRESS RELEASE

published on 08/13/2025 at 06:30, 10 months 15 days ago

Formycon confirms full-year guidance following business development in line with plan – working capital raised
Formycon AG confirms full-year guidance with successful business development. Working capital raised through oversubscribed corporate bond. Strong second half expected

Working Capital Business Development Formycon AG Corporate Bond Full-year Guidance
BRIEF

published on 08/04/2025 at 11:50, 10 months 24 days ago

Formycon AG obtient une note « fort achat » suite à des développements stratégiques

Formycon AG Emission D'obligations Mise À Jour Financière Recherche Sur Les Actions Lancement Du FYB202
BRIEF

published on 08/04/2025 at 11:50, 10 months 24 days ago

Formycon AG Gains Strong Buy Rating Amid Strategic Developments

Formycon AG Bond Issue Financial Update Equity Research FYB202 Launch
PRESS RELEASE

published on 08/04/2025 at 11:45, 10 months 24 days ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Formycon AG analysis, maintaining BUY rating with increased target price of €49. Company aims for 2025 revenue of €55-65m and improved financial position after new corporate bond issuance

First Berlin Equity Research BUY Rating Formycon AG Target Price Corporate Bond Issuance
BRIEF

published on 07/30/2025 at 06:35, 10 months 29 days ago

Formycon organise une conférence téléphonique et une participation à la conférence des investisseurs

Conseil D'administration Formycon AG Conférence Téléphonique Conférences D'investisseurs Résultats Financiers 2025
BRIEF

published on 07/30/2025 at 06:35, 10 months 29 days ago

Formycon Schedules Conference Call and Investor Conference Participation

Conference Call Investor Conferences Formycon AG Management Board 2025 Financial Results
PRESS RELEASE

published on 07/30/2025 at 06:30, 10 months 29 days ago

Formycon invites to conference call on 2025 half-year results and announces participation in international investor conferences in the 3rd quarter of 2025
Formycon AG to discuss 2025 half-year results in conference call and attend international investor conferences in the 3rd quarter of 2025. Details and registration info provided

Conference Call Investor Conferences Formycon AG Biosimilars 2025 Half-Year Results

Published on 06/27/2026 at 16:50, 1 day 5 hours ago

Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 20 hours ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 22 hours ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 23 hours ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 23 hours ago

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada

View all ACCESSWIRE

Published on 06/28/2026 at 20:00, 2 hours 28 minutes ago

CPI Property Group – Successful Hybrid Tender and New Issue
Published on 06/28/2026 at 19:45, 2 hours 43 minutes ago

PSP Swiss Property, Invitation Conference Call
Published on 06/28/2026 at 17:26, 5 hours 2 minutes ago

EQS-Adhoc: Correction of a release from 24/06/2026, 20:54 CET/CEST - Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements
Published on 06/27/2026 at 00:05, 1 day 22 hours ago

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 22 hours ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering

View all EQS

Published on 06/26/2026 at 17:45, 2 days 4 hours ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 2 days 4 hours ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 2 days 4 hours ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 2 days 7 hours ago

Safran information
Published on 06/26/2026 at 14:44, 2 days 7 hours ago

Information Safran

View all LES ECHOS COMFI WIRE

News